German Drugmaker Stada Seals Deal to Sell Cough Syrup in China - (Bloomberg via NewsPoints Desk)

  • Stada Arzneimittel has signed a partnership agreement with a unit of Shijiazhuang Yiling Pharmaceutical Co. to sell its cough and cold syrups in China, reported Bloomberg.

  • The deal will help Stada as it seeks to expand in the country, according to Carsten Cron, the German drugmaker's executive vice president for emerging markets.

  • "We're playing catch-up in China, but this partnership with Yiling will give us a much-needed boost in the country," said Cron, who joined Stada from Pfizer in 2018.

  • The partnership will also enable Stada to pursue a strategy in China's e-commerce market for consumer healthcare brands, and for Stada and Yiling Pharmaceutical to jointly develop high-potency raw materials, he added.

  • In Vietnam, Stada is seeking to boost sales after it recently obtained approval to set up a legal entity there, Cron said, adding its Vietnamese unit will soon start selling prescription and over-the-counter products and plans to collaborate with Pymepharco, a local generic drugmaker in which Stada holds a majority stake.

  • "We want to become the top player in Vietnam's generic market within the next three years," Cron said.

To read more NewsPoints articles, click here.